TrademarkDir
BETI-CEL
DEAD

Serial Number

79307811

Owner

Bluebird Bio (UK) Ltd.

Attorney

Christopher K. Albert

Filing Date

Feb 12, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BETI-CEL Trademark

Serial Number: 79307811

BETI-CEL is a trademark filed by Bluebird Bio (UK) Ltd. on February 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Trademark Details

Filing Date

February 12, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances for treating genetic diseases, namely beta-thalassemia requiring regular red blood cell transfusions

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 2, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
May 13, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 12, 2024 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 23, 2023 ADCH
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 12, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 12, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 12, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2022 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 26, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 7, 2022 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 26, 2022 ADCH
REFUSAL PROCESSED BY IB
May 16, 2022 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 12, 2022 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2022 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2021 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Oct 20, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2021 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2021 DOCK
CHANGE OF OWNER RECEIVED FROM IB
Aug 13, 2021 CHLD
APPLICATION FILING RECEIPT MAILED
Apr 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 5, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 1, 2021 REPR

Related Trademarks

More from this Owner

G GENETIX BIOTHERAPEUTICS logo

G GENETIX BIOTHERAPEUTICS

G GENETIX BIOTHERAPEUTICS logo

G GENETIX BIOTHERAPEUTICS

G logo

G

GENETIX BIOTHERAPEUTICS

GENETIX BIOTHERAPEUTICS

G logo

G

ZYNTEGLO

ZYNTEGLO